Design, Synthesis, Characterization, and Evaluation of the Anti-HT-29 Colorectal Cell Line Activity of Novel 8-Oxyquinolinate-Platinum(II)-Loaded Nanostructured Lipid Carriers Targeted with Riboflavin.
Autorzy:
Boztepe T; Laboratorio de Nanobiomateriales, CINDEFI-Departamento de Química, Facultad de Ciencias Exactas, Universidad Nacional de La Plata-CONICET, La Plata B1900, Argentina. Scioli-MontotoS; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), La Plata B1904, Argentina.; Laboratorio de Investigación y Desarrollo de Bioactivos (LIDeB), Departamento de Ciencias Biológicas, Facultad de Ciencias Exactas, Universidad Nacional de La Plata (UNLP), La Plata B1900, Argentina. Gambaro RC; Instituto de Genética Veterinaria (IGEVET, UNLP-CONICET La Plata), Facultad de Ciencias Veterinarias Universidad Nacional de La Plata (UNLP), La Plata B1900, Argentina. Ruiz ME; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), La Plata B1904, Argentina.; Laboratorio de Investigación y Desarrollo de Bioactivos (LIDeB), Departamento de Ciencias Biológicas, Facultad de Ciencias Exactas, Universidad Nacional de La Plata (UNLP), La Plata B1900, Argentina. Cabrera S; Departamento de Química Inorgánica, Universidad Autónoma de Madrid, 28049 Madrid, Spain. Alemán J; Departamento de Química Orgánica, Universidad Autónoma de Madrid, 28049 Madrid, Spain. Islan GA; Laboratorio de Nanobiomateriales, CINDEFI-Departamento de Química, Facultad de Ciencias Exactas, Universidad Nacional de La Plata-CONICET, La Plata B1900, Argentina. Castro GR; Max Planck Laboratory for Structural Biology, Chemistry and Molecular Biophysics of Rosario (MPLbioR, UNR-MPIbpC), Partner Laboratory of the Max Planck Institute for Biophysical Chemistry (MPIbpC, MPG), Centro de Estudios Interdisciplinarios (CEI), Universidad Nacional de Rosario, Rosario S2000, Argentina.; Nanomedicine Research Unit (Nanomed), Center for Natural and Human Sciences (CCNH), Universidade Federal do ABC (UFABC), Santo André 09210-580, SP, Brazil. León IE; CEQUINOR (UNLP, CCT-CONICET La Plata, Asociado a CIC), Departamento de Química, Facultad de Ciencias Exactas, Universidad Nacional de La Plata, La Plata B1900, Argentina.; Cátedra de Fisiopatología, Departamento de Ciencias Biológicas, Facultad de Ciencias Exactas, Universidad Nacional de La Plata, La Plata B1900, Argentina.
Pokaż więcej
Źródło:
Pharmaceutics [Pharmaceutics] 2023 Mar 22; Vol. 15 (3). Date of Electronic Publication: 2023 Mar 22.
The outcome of reduced intensity allogeneic stem cell transplantation and autologous stem cell transplantation when performed as a first transplant strategy in relapsed follicular lymphoma: an analysis from the Lymphoma Working Party of the EBMT
Genetic and phenotypic characterisation of HIV-associated aggressive B-cell non-Hodgkin lymphomas, which do not occur specifically in this population: diagnostic and prognostic implications.
Autorzy:
Baptista MJ; Department of Hematology, ICO-Germans Trias i Pujol Hospital, Josep Carreras Leukaemia Research Institute (IJC), Universitat Autònoma de Barcelona, Badalona, Spain. Tapia G; Department of Pathology, Hospital Germans Trias i Pujol, IGTP, Universitat Autònoma de Barcelona, Badalona, Spain. Muñoz-Marmol AM; Department of Pathology, Hospital Germans Trias i Pujol, IGTP, Universitat Autònoma de Barcelona, Badalona, Spain. Muncunill J; Department of Hematology, ICO-Germans Trias i Pujol Hospital, Josep Carreras Leukaemia Research Institute (IJC), Universitat Autònoma de Barcelona, Badalona, Spain. Garcia O; Department of Hematology, ICO-Germans Trias i Pujol Hospital, Josep Carreras Leukaemia Research Institute (IJC), Universitat Autònoma de Barcelona, Badalona, Spain. MontotoS; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK. Gribben JG; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK. Calaminici M; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK. Martinez A; Department of Pathology, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain. Veloza L; Department of Pathology, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain. Martínez-Trillos A; Department of Hematology, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain. Aldamiz T; Department of Infectious Diseases, Hospital Gregorio Marañón, Madrid, Spain. Menarguez J; Department of Pathology, Hospital Gregorio Marañón, Madrid, Spain. Terol MJ; Department of Hematology and Oncology, Hospital Clínic Universitari de València, Valencia, Spain. Ferrandez A; Department of Pathology, Hospital Clínic Universitari de València, Valencia, Spain. Alcoceba M; Department of Hematology, Hospital Universitario de Salamanca (HUS/IBSAL), CIBERONC and Centro de Investigación del Cáncer-IBMCC (USAL-CSIC), Salamanca, Spain. Briones J; Department of Hematology, Hospital de la Santa Creu i Sant Pau, Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Spain. González-Barca E; Department of Hematology, ICO-Hospital Duran i Reynals, L'Hospitalet de Llobregat, Spain. Climent F; Department of Pathology, Hospital Universitari de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Badalona, Spain. Muntañola A; Department of Clinical Hematology, Hospital Universitari Mutua de Terrassa, Terrassa, Spain. Moraleda JM; Department of Hematology, Hospital Clinico Universitario Virgen de la Arrixaca, Murcia, Spain. Provencio M; Department of Medical Oncology, Hospital Universitario Puerta De Hierro, Majadahonda, Spain. Abrisqueta P; Department of Hematology, Hospital Vall d'Hebrón, Barcelona, Spain. Abella E; Department of Hematology, Hospital del Mar, Barcelona, Spain. Colomo L; Department of Pathology, Hospital del Mar, Barcelona, Spain. García-Ballesteros C; Department of Hematology, Hospital Arnau de Vilanova, Valencia, Spain. Garcia-Caro M; Department of Hematology, Hospital de Mataro, Barcelona, Spain. Sancho JM; Department of Hematology, ICO-Germans Trias i Pujol Hospital, Josep Carreras Leukaemia Research Institute (IJC), Universitat Autònoma de Barcelona, Badalona, Spain. Ribera JM; Department of Hematology, ICO-Germans Trias i Pujol Hospital, Josep Carreras Leukaemia Research Institute (IJC), Universitat Autònoma de Barcelona, Badalona, Spain. Mate JL; Department of Pathology, Hospital Germans Trias i Pujol, IGTP, Universitat Autònoma de Barcelona, Badalona, Spain. Navarro JT; Department of Hematology, ICO-Germans Trias i Pujol Hospital, Josep Carreras Leukaemia Research Institute (IJC), Universitat Autònoma de Barcelona, Badalona, Spain.
Pokaż więcej
Źródło:
Histopathology [Histopathology] 2022 Dec; Vol. 81 (6), pp. 826-840. Date of Electronic Publication: 2022 Oct 04.
The role of in vivo T-cell depletion on reduced-intensity conditioning allogeneic stem cell transplantation from HLA-identical siblings in patients with follicular lymphoma
Long‐term outcome of patients receiving haematopoietic allogeneic stem cell transplantation as first transplant for high‐risk Hodgkin lymphoma: a retrospective analysis from the Lymphoma Working Party‐EBMT.
Complications of Autologous Stem Cell Transplantation in Multiple Myeloma: Results from the CALM Study.
Autorzy:
Waszczuk-Gajda A; Department of Hematology, Transplantation and Internal Medicine, University Clinical Centre-The Medical University of Warsaw, 02-097 Warsaw, Poland. Penack O; Charité Universitätsmedizin Berlin, 10771 Berlin, Germany. Sbianchi G; Tor Vergata University, 00133 Rome, Italy. Koster L; EBMT Data Office Leiden, 2333 AA Leiden, The Netherlands. Blaise D; Institut Paoli Calmettes, 13009 Marseille, France. Reményi P; Dél-Pesti Centrumkórház, 1097 Budapest, Hungary. Russell N; Nottingham University, Nottingham NG7 2QL, UK. Ljungman P; Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska Comprehensive Cancer Center, Karolinska University Hospital Huddinge, 17177 Stockholm, Sweden.; Division of Hematology, Department of Medicine Huddinge, Karolinska Institute, 171 77 Stockholm, Sweden. Trneny M; University Hospital, 12808 Prague, Czech Republic. Mayer J; University Hospital Brno, 62500 Brno, Czech Republic. Iacobelli S; Tor Vergata University, 00133 Rome, Italy. Kobbe G; Heinrich Heine Universitaet, 40225 Duesseldorf, Germany. Scheid C; University of Cologne, 50923 Cologne, Germany. Apperley J; Imperial College, London SW7-2BX, UK. Touzeau C; CHU Nantes, 44000 Nantes, France. Lenhoff S; Skanes University Hospital, 23262 Lund, Sweden. Jantunen E; Department of Medicine, University of Eastern Finland and Hospital District of North Carelia, Kuopio University Hospital, 70211 Kuopio, Finland. Anagnostopoulos A; George Papanicolaou General Hospital, 57010 Thessaloniki, Greece. Paris L; Division of Hematology, SST Papa Giovanni XXIII, 24127 Bergamo, Italy. Browne P; Hope Directorate, D08 NHY1 Dublin, Ireland. Thieblemont C; Hôpital St. Louis, 75010 Paris, France. Schaap N; Radboud University Medical Centre, Department of Hematology, 6525 GA Nijmegen, The Netherlands. Sierra J; Hospital Santa Creu i Sant Pau, 08001 Barcelona, Spain. Yakoub-Agha I; CHU de Lille, 59000 Lille, France. Garderet L; Centre de Recherche Saint-Antoine, Sorbonne Université-INSERM, UMR_S 938, 75013 Paris, France.; Département d'Hématologie et de Thérapie Cellulaire, Assistance Publique-Hôpitaux de Paris, Hôpital Pitié Salpetrière, 75012 Paris, France. Styczynski J; Department of Pediatric Hematology and Oncology, Collegium Medicum UMK, 85-067 Bydgoszcz, Poland. Schoemans H; Department of Hematology, University Hospitals Leuven, 3000 Leuven, Belgium.; Department of Public Health and Primary Care, ACCENT VV, KU Leuven-University of Leuven, 3000 Leuven, Belgium. Moiseev I; R.M. Gorbacheva Memorial Institute of Hematology, Oncology and Transplantation, Pavlov University, 197022 Saint-Petersburg, Russia. Duarte RF; Hospital Universitario Puerta de Hierro Majadahonda-Universidad Autónoma de Madrid, 28222 Madrid, Spain. Peric Z; Department of Internal Medicine, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia. MontotoS; Department of Haemato-Oncology, St Bartholomew's Hospital, Barts Health NHS Trust, London EC1A 7BE, UK. van Biezen A; EBMT Data Office Leiden, 2333 AA Leiden, The Netherlands. Mikulska M; Division of Infectious Diseases, Department of Health Sciences (DISSAL), University of Genoa, 16121 Genoa, Italy.; Division of Infectious Diseases, IRC CS Ospedale Policlinico San Martino, 16132 Genoa, Italy. Aljurf M; Section of Adult Haematolgy/BMT, King Faisal Specialist Hospital & Research Centre Oncology, Riyadh 11564, Saudi Arabia. Ruutu T; Comprehensive Cancer Center, Department of Hematology, Helsinki University Hospital and University of Helsinki, 00290 Helsinki, Finland.; Clinical Research Institute, Helsinki University Hospital and University of Helsinki, 00280 Helsinki, Finland. Kröger N; University Hospital Eppendorf, 20246 Hamburg, Germany. Morris C; Belfast City Hospital, Belfast BT9 7AB, UK. Koenecke C; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, 30625 Hannover, Germany. Schoenland S; Department of Internal Medicine V, Division of Hematology/Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany. Basak GW; Department of Hematology, Transplantation and Internal Medicine, University Clinical Centre-The Medical University of Warsaw, 02-097 Warsaw, Poland.
Pokaż więcej
Źródło:
Journal of clinical medicine [J Clin Med] 2022 Jun 20; Vol. 11 (12). Date of Electronic Publication: 2022 Jun 20.
Long-term follow-up of high-dose treatment with autologous haematopoietic progenitor cell support in 693 patients with follicular lymphoma: an EBMT registry study
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
